Immunology explores the intricate defense systems that keep our bodies safe from infections and disease. This field examines how our immune cells recognize threats, coordinate responses, and maintain a delicate balance between fighting invaders and avoiding self-harm. From understanding vaccine mechanisms to investigating autoimmune disorders, these studies reveal the dynamic biology protecting human health every day.

On Gist.Science, we ensure these critical discoveries remain accessible to everyone. We automatically process every new preprint in this category as it appears on bioRxiv, transforming complex research into both plain-language explanations and detailed technical summaries. This approach allows readers to grasp the core findings without getting lost in dense jargon, while still providing the depth needed for scientific inquiry.

Below are the latest immunology papers from bioRxiv, each accompanied by our curated summaries to help you navigate the newest breakthroughs in the field.

🛡️ immunology

SMAD2: Regulatory junction of TGF-β and antigen signaling in mast cells

This study reveals that SMAD2 acts as a critical regulatory hub in mast cells, where its absence enhances proliferation and TGF-β-mediated SMAD1/5 signaling while paradoxically abolishing antigen-induced pro-inflammatory cytokine production, highlighting its dual role in balancing suppressive and inflammatory responses.

Bronneberg, G., Meurer, S. K., Kauffmann, M., Kuo, C.-C., Liedtke, C., Weiskirchen, R., Huber, M.2026-04-17
🛡️ immunology

Latent Effector Capacity Governs Reversible T Cell Exhaustion: A Mathematical Model for Mechanistically Predictive AI in PD-1 Blockade

This paper proposes a mathematical framework that resolves the paradox of reversible T cell exhaustion by defining a "latent effector capacity" state, demonstrating that PD-1 blockade unmasks pre-existing potential rather than reprogramming cells, and establishing a foundation for predictive AI models that distinguish between reversible suppression and irreversible loss of function.

Liew, A. Y., Li, Y., Dong, H.2026-04-17
🛡️ immunology

Distinct prokaryotic gut microbiome and proviral-immune axes ofpathophysiology in Sickle Cell Disease

This study identifies a distinct prokaryotic gut microbiome characterized by reduced diversity and altered metabolic pathways, alongside a unique proviral-immune axis involving domesticated prophages and aged-like neutrophils, which together drive the pathophysiology of Sickle Cell Disease.

Flamholz, Z. N., De Los Santos, J., Ireland, K., Keenan, J., Kazmi, J. S., Mahant, A. M., Correa, A., Frenette, P., Hero (…)2026-04-15
🛡️ immunology

Deciphering antigen-driven T cell responses through vectorized TCRdist sequence neighborhood quantification

This paper introduces a scalable computational framework that utilizes vectorized TCR embeddings and a novel shuffling-based background model to efficiently identify significantly neighbor-enriched T cell receptor sequences, thereby enabling robust, antigen-agnostic profiling of T cell responses to vaccination and infection while distinguishing antigen-driven convergence from stochastic recombination biases.

Valkiers, S., Mayer-Blackwell, K., Yeh, A. C., Van Deuren, V. M. L., Fiore-Gartland, A., Hill, G., Laukens, K., Meysman (…)2026-04-14
🛡️ immunology

The role of integrins in T cell-mediated resistance to Cryptosporidium parvum

This study reveals that while cDC1s drive integrin expression on Cryptosporidium-specific T cells, resistance to the parasite relies on an unexpected 4β7-independent trafficking mechanism where integrin L is essential for T cell accumulation in the gut and effective parasite control.

Merolle, M., Haskins, B., Engiles, J. B., Hart, A., Cohn, I., Howard, C., O'Dea, K., Byerly, J. H., Christian, D. A., St (…)2026-04-14
🛡️ immunology

KLRG1 identifies circulating cytotoxic CD4 T cells with selective anti-tumor function in human cancer

This study identifies KLRG1 as a defining surface marker for circulating cytotoxic CD4+ T cells in melanoma patients that selectively kill MHC class II-expressing tumor cells via a granulysin-dependent mechanism while sparing antigen-presenting cells, and reveals that tumor-derived IL-6 impairs this function by driving a transition to a T follicular helper phenotype.

Cenerenti, M., Garnica, J., Saillard, M., Gueguen, P., Wolf, B., Lemaitre, F., Marone, R., Liu, Y. C., Cornu, A., Dumez (…)2026-04-14